BiotechX Europe

The programme is designed to connect stakeholders across drug discovery, clinical trials, R&D, and data science—spotlighting how multi-omic data, analytics and digital transformation are accelerating therapeutic development and improving patient care. It combines a multi-track conference with an exhibition and structured networking designed to support partnering and practical knowledge exchange.

Who the audience is and how many attend

Audience

• Biotech and pharma R&D leaders (drug discovery, translational, clinical development)
• Data science, bioinformatics, genomics and multi-omics teams
• Digital transformation and innovation leaders in healthcare and pharma
• Tech pioneers and platform providers (AI/ML, cloud/data infrastructure, analytics)
• Investors and strategic partners active in data-driven life sciences

Scale

• Attendees: 3,000+
• Speakers: 400+
• Exhibitors: 150+
• Biotech start-ups: 100+

What to expect

• Three days of conference content focused on data, AI and genomics for pharma and healthcare innovation
• A large exhibition of solution providers across drug discovery, data management and AI
• Built-in 1-to-1 networking designed to connect delegates for targeted meetings and partnering
• A highly cross-functional audience spanning science, tech and commercial decision-makers in life sciences